TC BioPharm
Valuation
$38.1M
Funding
$0
Founded
2013
TC BioPharm revenue, CEO Rahul Shinghal, team size, customer count, churn, and more in 2026.
TC BioPharm (Nasdaq: TCBP) is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease.
Last updated
TC BioPharm Revenue
We do not have information about TC BioPharm's revenue yet.
TC BioPharm Valuation, Funding Rounds
TC BioPharm's most recent disclosed valuation is $38.1M.
TC BioPharm is a bootstrapped SaaS company, self-funded since its founding in 2013, with no outside investment to date.
| Year | Round | Amount | Valuation | % Sold |
|---|
TC BioPharm Employees & Team Size
We do not have information about TC BioPharm's team yet.
Founder / CEO
Rahul Shinghal
Rahul Shinghal is listed as Founder / CEO at TC BioPharm.
Q&A
| Question | Answer |
|---|---|
| What's your age? | - |
| Favorite online tool? | - |
| Favorite book? | - |
| Favorite CEO? | - |
| Advice for 20 year old self | - |
Customers
We do not have customer count information for TC BioPharm yet.
Frequently Asked Questions about TC BioPharm
What is TC BioPharm's revenue?
GetLatka has not confirmed a public revenue figure for TC BioPharm.
Who is the CEO of TC BioPharm?
The CEO of TC BioPharm is Rahul Shinghal.
How much funding does TC BioPharm have?
TC BioPharm raised $0.
How many employees does TC BioPharm have?
TC BioPharm has 0 employees.
Where is TC BioPharm headquarters?
TC BioPharm is headquartered in Holytown, Scotland, United Kingdom.
Source Attribution
Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.
Company data last updated .